1. The anti-inflammatory effect of the gut lactic acid bacteria-generated metabolite 10-oxo-cis-6,trans-11-octadecadienoic acid on monocytes.
- Author
-
Hagiwara, Shuhei, Nagata, Kazuki, Kasakura, Kazumi, Sakata, Fumiya, Kishino, Shigenobu, Ogawa, Jun, Yashiro, Takuya, and Nishiyama, Chiharu
- Subjects
- *
LACTIC acid , *G protein coupled receptors , *UNSATURATED fatty acids , *BACTERIAL metabolites , *LACTIC acid bacteria , *MICROBIAL metabolites , *LIPOPOLYSACCHARIDES - Abstract
We evaluated the effect of gut bacterial metabolites of polyunsaturated fatty acids on inflammation and found that 10-oxo- cis -6, trans -11-octadecadienoic acid (γKetoC) strikingly suppressed LPS-induced IL-6 release from bone marrow-derived macrophages (BMMs), which was accompanied by reduced mRNA expression of Il6 , TNF , and Il1b. γKetoC decreased the cAMP concentration in BMMs, suggesting that γKetoC stimulated G protein-coupled receptors. A Gq agonist significantly suppressed LPS-induced IL-6 expression in BMMs, whereas a Gi inhibitor partially abrogated γKetoC-mediated IL-6 suppression. Cytosolic Ca2+ was markedly increased by γKetoC, which was partly but not fully abrogated by an ion channel inhibitor. Taken together, these data suggest that γKetoC suppresses inflammatory cytokine expression in macrophages primarily through Gq and partially through Gi. γKetoC suppressed osteoclast development and IL-6 expression in synovial fibroblasts from rheumatoid arthritis (RA) patients, suggesting the beneficial effect of γKetoC on the prevention or treatment of RA. • A gut lactic acid bacteria metabolite, γKetoC, suppresses activation of macrophages. • γKetoC decreases inflammatory cytokine release from macrophages via GPCR. • γKetoC inhibits osteoclast development and IL-6 expression in synovial fibroblasts. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF